These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32481410)

  • 1. Management of locally advanced synchronous colorectal and prostate cancers: A case report.
    Tey YQ; Ravi K; Chong CS; Chiong E; Ho J; Tey JCS; Ho F
    Medicine (Baltimore); 2020 May; 99(22):e20336. PubMed ID: 32481410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The curative management of synchronous rectal and prostate cancer.
    Lavan NA; Kavanagh DO; Martin J; Small C; Joyce MR; Faul CM; Kelly PJ; O'Riordain M; Gillham CM; Armstrong JG; Salib O; McNamara DA; McVey G; O'Neill BD
    Br J Radiol; 2016; 89(1057):20150292. PubMed ID: 26539631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial high-dose-rate brachytherapy as a boost in synchronous prostate and rectal cancer treatment: case report and literature review.
    Konat-Bąska K; Chicheł A; Staszek-Szewczyk U; Maciejczyk A; Matkowski R
    J Contemp Brachytherapy; 2020 Apr; 12(2):181-187. PubMed ID: 32395143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical management of rectal cancer with synchronous treatment of prostate cancer.
    Brière R; Martin AG; Letarte F; Fournier FR; Bouchard P; Drolet S
    Langenbecks Arch Surg; 2024 Apr; 409(1):133. PubMed ID: 38642125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Therapeutic Challenges in a Patient with Synchronous Very High-Risk Prostate Adenocarcinoma and Anal Carcinoma.
    Wallach J; Youssef I; Leaf A; Schwartz D
    Curr Oncol; 2022 Jan; 29(1):377-382. PubMed ID: 35049707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of synchronous rectal and prostate cancer.
    Kavanagh DO; Quinlan DM; Armstrong JG; Hyland JM; O'Connell PR; Winter DC
    Int J Colorectal Dis; 2012 Nov; 27(11):1501-8. PubMed ID: 22451255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study on the efficacies of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist in neoadjuvant androgen deprivation therapy combined with transperineal prostate brachytherapy for localized prostate cancer.
    Miki K; Sasaki H; Kido M; Takahashi H; Aoki M; Egawa S
    BMC Cancer; 2016 Sep; 16(1):708. PubMed ID: 27586506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications and outlooks of radiohormonal therapy of high-risk prostate cancers].
    Latorzeff I; Sargos P; Créhange G; Belkacémi Y; Azria D; Hasbini A; Dubergé T; Toledano A; Graff-Cailleaud P; Chapet O; Hennequin C; de Crevoisier R; Supiot S; Pasquier D
    Cancer Radiother; 2020 Apr; 24(2):143-152. PubMed ID: 32057646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer: are high-risk patients good candidates?
    Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Masui K; Yoshioka Y; Narumi Y; Oka T; Tanaka E
    Strahlenther Onkol; 2014 Oct; 190(11):1015-20. PubMed ID: 24838407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancer.
    Vargas CE; Alam NB; Terk M; Niska JR; Cesaretti J; Swartz D; Vashi A; Kasraeian A; West CS; Blasser M; Moore C
    Cancer Treat Res Commun; 2019; 19():100119. PubMed ID: 30772671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in patterns of concurrent androgen deprivation therapy use based on dose escalation with external beam radiotherapy vs. brachytherapy boost for prostate cancer.
    Mohiuddin JJ; Narayan V; Venigalla S; Vapiwala N
    Brachytherapy; 2019; 18(3):322-331. PubMed ID: 30862436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage of locally recurrent prostate cancer after external beam radiation using reduced-dose brachytherapy with neoadjuvant plus adjuvant androgen deprivation.
    Baumann BC; Baumann JC; Christodouleas JP; Soffen E
    Brachytherapy; 2017; 16(2):291-298. PubMed ID: 28139422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary treatment of synchronous primary rectal and prostate cancers.
    Colonias A; Farinash L; Miller L; Jones S; Medich DS; Greenberg L; Miller R; Parda DS
    Nat Clin Pract Oncol; 2005 May; 2(5):271-4; quiz 1 p following 274. PubMed ID: 16264963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of a prospective trial of trimodality therapy of weekly paclitaxel, radiation, and androgen deprivation in high-risk prostate cancer with or without prior prostatectomy.
    Hussain A; Wu Y; Mirmiran A; DiBiase S; Goloubeva O; Bridges B; Mannuel H; Engstrom C; Dawson N; Amin P; Kwok Y
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):167-74. PubMed ID: 21036487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium.
    Ishiyama H; Kamitani N; Kawamura H; Kato S; Aoki M; Kariya S; Matsumura T; Kaidu M; Yoshida K; Hashimoto Y; Noda Y; Lim KHC; Kawase T; Takahashi T; Inaba K; Kumano M; Yoshikawa N; Yoshioka Y; Nakamura K; Hiratsuka J; Itami J; Hayakawa K
    Brachytherapy; 2017; 16(3):503-510. PubMed ID: 28222973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous prostate and rectal adenocarcinomas irradiation utilising volumetric modulated arc therapy.
    Ng SP; Tran T; Moloney P; Sale C; Mathlum M; Ong G; Lynch R
    J Med Radiat Sci; 2015 Dec; 62(4):286-91. PubMed ID: 27512575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer.
    Mason MD; Parulekar WR; Sydes MR; Brundage M; Kirkbride P; Gospodarowicz M; Cowan R; Kostashuk EC; Anderson J; Swanson G; Parmar MK; Hayter C; Jovic G; Hiltz A; Hetherington J; Sathya J; Barber JB; McKenzie M; El-Sharkawi S; Souhami L; Hardman PD; Chen BE; Warde P
    J Clin Oncol; 2015 Jul; 33(19):2143-50. PubMed ID: 25691677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.
    Warde P; Mason M; Ding K; Kirkbride P; Brundage M; Cowan R; Gospodarowicz M; Sanders K; Kostashuk E; Swanson G; Barber J; Hiltz A; Parmar MK; Sathya J; Anderson J; Hayter C; Hetherington J; Sydes MR; Parulekar W;
    Lancet; 2011 Dec; 378(9809):2104-11. PubMed ID: 22056152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant androgen deprivation therapy under an early salvage policy for patients with T3-T4N0M0 prostate cancer.
    Mizowaki T; Norihisa Y; Takayama K; Ikeda I; Inokuchi H; Nakamura K; Kamba T; Inoue T; Kamoto T; Ogawa O; Hiraoka M
    Int J Clin Oncol; 2016 Feb; 21(1):148-55. PubMed ID: 26141133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemoradiation followed by interstitial prostate brachytherapy for synchronous prostate and rectal cancer.
    Qiu H; Herman JM; Ahuja N; DeWeese TL; Song DY
    Pract Radiat Oncol; 2012; 2(4):e77-e84. PubMed ID: 24674189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.